Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

• Váldodahkkit: Hamdy SM (Dahkki), Abdel-Naseer M (Dahkki), Shehata HS (Dahkki), Hassan A (Dahkki), Elmazny A (Dahkki), Shalaby NM (Dahkki), Abokrysha NT (Dahkki), Kishk NA (Dahkki), Nada MAF (Dahkki), Ahmed SM (Dahkki), Hegazy MI (Dahkki), Mekkawy D (Dahkki), Mourad HS (Dahkki), Abdelalim A (Dahkki), Berger T (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Dove Medical Press, 2020-07-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Sherif M Hamdy,1 Maged Abdel-Naseer,1 Hatem S Shehata,1 Amr Hassan,1 Alaa Elmazny,1 Nevin M Shalaby,1 Noha T Abokrysha,1 Nirmeen A Kishk,1 Mona AF Nada,1 Sandra M Ahmed,1 Mohamed I Hegazy,1 Doaa Mekkawy,1 Husam S Mourad,1 Ahmed Abdelalim,1 Thomas Berger2 1Neurology Department, Faculty of Medicine, C...